DP-b99 (D-Pharm).

  • Pollen K Yeung
  • Published 2004 in Current opinion in investigational drugs


DP-b99 is a derivative of the calcium chelator BAPTA that is under development as a neuroprotectant for the potential treatment of stroke, head trauma and neurological damage associated with coronary artery bypass graft. By March 2003, phase II clinical trials in acute stroke and traumatic brain injury were ongoing. 


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.